Gene Editing Therapy Casgevy Now Funded In 8 Countries But French Access Withdrawn

 
• By Eliza Slawther
  
Casgevy is the first approved product to use CRISPR/Cas9 technology, which was identified as a gene editing tool in 2012. (Shutterstock)

More from Cell & Gene Therapies

More from Government Payers